Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain scans reveal Alzheimer's clues in frail seniors

NCT ID NCT03129269

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at 344 frail older adults (70+) with memory issues to see how many have Alzheimer's-related brain changes. Participants had MRI and PET scans to detect amyloid plaques. The goal was to understand the link between frailty, memory loss, and Alzheimer's pathology.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help identify which frail older adults with memory problems have Alzheimer's disease pathology, guiding future treatment decisions.
What could go wrong
This is an observational study, not a treatment trial. It does not test any therapy, so it cannot directly improve health. Results may not apply to all older adults.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

344 people

The number who actually took part.

Started

Jan 2017

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

70 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female and male individuals referred to the Toulouse Frailty Clinic with an objective memory impairment (CDR=0.5 or CDR=1) * Age ≥ 70 years * At least 1 Fried-criterion * Informed consent signed by the patient * Having an informant accompanying or available by phone * Individuals affiliated to a healthcare scheme. * \- Willing to be informed in case of a new pathology discovered through medical examination Extension study (Cog-Frail Plus): * COGFRAIL study participants still included in the study and completing their last visit (M 24) * Having a family member or legal representant to sign the consent form if MMSE score \<20 at the last visit (M24) Exclusion Criteria: * Individuals presenting severe visual or auditory difficulties which may interfere with the completion of neuropsychological and functional assessments. * Presence of any pathology or severe clinical or psychological condition that, according to the investigator, might interfere with study results or may expose the participants to additional risks. * Individuals who are robust according to the Fried criteria (0 criteria) * Individuals who are dependent (Activities of Daily Living (ADL) \<4) * Individuals who have a major deterioration in global cognitive function (Mini Mental State Examination (MMSE) \<20) * Subjects deprived of their liberty by administrative or judicial decision, or under guardianship or admitted to a healthcare or social institution (subjects in non-assisted living facilities could be recruited); Exclusion criteria for MRI scanning : * Claustrophobia * Trauma or surgery which may have left ferromagnetic material in the body, including pacemakers * History of neurosurgery or aneurism Extension study (Cog-Frail Plus): * Presence of any severe pathology that, according to the investigator, might interfere with study results or may expose the participants to additional risks. * Subjects deprived of their liberty by administrative or judicial decision, or under guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frail elderly are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Toulouse University Hospital (CHU de Toulouse)

    Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.